a developer of medical devices for cardiovascular and kidney diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, CRMD has been loosely correlated with CNTA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CRMD jumps, then CNTA could also see price increases.
Ticker / NAME | Correlation To CRMD | 1D Price Change % | ||
---|---|---|---|---|
CRMD | 100% | -6.41% | ||
CNTA - CRMD | 37% Loosely correlated | N/A | ||
PGEN - CRMD | 36% Loosely correlated | -3.64% | ||
ACLX - CRMD | 35% Loosely correlated | -3.81% | ||
ERAS - CRMD | 35% Loosely correlated | -5.19% | ||
ANAB - CRMD | 35% Loosely correlated | -5.28% | ||
More |
Ticker / NAME | Correlation To CRMD | 1D Price Change % |
---|---|---|
CRMD | 100% | -6.41% |
diseases theme (42 stocks) | 28% Poorly correlated | +1.03% |
medical research theme (128 stocks) | 27% Poorly correlated | +0.46% |
medical service theme (156 stocks) | 26% Poorly correlated | +0.31% |
cardiovascular theme (12 stocks) | 24% Poorly correlated | +0.92% |
medical devices theme (64 stocks) | 19% Poorly correlated | +0.44% |